March 2015 FDA Recall Drug by Actavis Laboratories, Fl, Inc.
D-0488-2015 - Presence of Foreign Substance; fine residue or dust identified as aluminum may be on exterior of the capsule shell

This Class III drug recall was voluntarily initiated by Actavis Laboratories, Fl, Inc. on March 26, 2015 for the product Drug. The FDA reported the reason for recall as presence of foreign substance; fine residue or dust identified as aluminum may be on exterior of the capsule shell. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0488-2015

Reason for Recall
Presence of Foreign Substance; fine residue or dust identified as aluminum may be on exterior of the capsule shell
Initiated
03-26-2015
Reported
04-22-2015
Quantity
2,628 bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Actavis Laboratories, FL, Inc.
Cartia XT (diltiazem HCl extended-release capsules, USP), Once-A-Day Dosage, 300 mg, 90-count bottles, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA --- NDC 62037-0600-90

Batch or Lot Expiration Information

Lot# 956000M, Exp. Aug 2016; UPC 3-6203760090-6